SCHEDULE: SeaStar Medical: Ayrton Capital's 2.6% Passive Stake
Schedule 13G Amendment
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri disclose a passive 2.6% beneficial ownership stake in SeaStar Medical Holding Corp, primarily through warrants.
Summary
- Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri collectively reported a beneficial ownership of 294,361 shares of SeaStar Medical Holding Corp common stock.
- This represents 2.6% of the company's outstanding common stock.
- The ownership is primarily derived from 294,361 shares issuable upon the exercise of certain warrants.
- The shares issuable from warrants are subject to a 9.99% beneficial ownership blocker.
- The percentage is calculated based on 11,203,752 shares outstanding as of June 12, 2025, plus the 294,361 warrant shares.
- The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral. This is a routine passive ownership disclosure (Schedule 13G Amendment No. 2) indicating a 2.6% stake, primarily from warrants. It does not contain information that would significantly alter the company's perceived value or prospects.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Alto Opportunity Master Fund, SPC Segregated Master Portfolio B is a private investment vehicle.
- Ayrton Capital LLC serves as the investment manager for Alto Opportunity Master Fund.
- Waqas Khatri serves as the managing member of Ayrton Capital LLC and a Director of Alto Opportunity Master Fund.
Stakeholder Impact
- Shareholders: Provides transparency regarding a passive ownership stake by an investment fund and its principals.
Key Dates
| Date | Description |
|---|---|
| 2025-06-12 | Date as of which 11,203,752 shares of Common Stock were outstanding, as stated in the Issuer's Form 424B4 Prospectus filing. |
| 2025-06-23 | Date of the Issuer's Form 424B4 Prospectus filing. |
| 2025-06-30 | Date of event which requires filing of this statement (ownership determination date). |
| 2025-08-13 | Date of signing of the Schedule 13G Amendment No. 2. |
Keywords
SeaStar Medical Holding Corp, Common Stock, Schedule 13G, Beneficial Ownership, Warrants, Ayrton Capital LLC, Alto Opportunity Master Fund, Waqas Khatri, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.